Silence Therapeutics Inc. (SLN): Balans kapitallashuviga qarzlar

Silence Therapeutics Corp (SLN) tovar belgisi

Silence Therapeutics (SLN) — xavfli qon kasalliklariga qarshi kurashish uchun aniq RNA interferentsiyasi usullariga ixtisoslashgan nufuzli biofarmatsevtika ishtirokchisidir. Qimmatqaymolarning bozor dinamikasi 0.00 ning joriy ko'rsatkichini aks ettiradi. Silence Therapeutics (SLN) innovatsiyalarga e'tiborni qaratishni saqlab qolish uchun ishlab chiqarish va sinovlar bo'yicha tashqi pudratchilarga tayanadi. Qat'iy patent nazorati va ko'p yillik tadqiqotlar ushbu sektordagi yangi ishtirokchilar uchun yengib bo'lmas kirish to'siqlarini yaratadi.

SLN Silence Therapeutics Corp: Qarzning balans kapitallashuviga nisbati 21.06.2023 - 28.10.2026 oraligʻida

Silence Therapeutics PLC (SLN) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Silence Therapeutics|SLN - Tahlilchilar median maqsadi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Silence Therapeutics Corp|SLN - Kompaniyani sotib olish narxi
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Silence Therapeutics|SLN - Kompaniyaning balans qiymati|Bozor kapitallashuvining balans qiymatiga nisbati silence-therapeutics.com|SLN - Kompaniya aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Silence Therapeutics|SLN - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning kapitalga nisbati Silence Therapeutics Inc.|SLN - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Silence Therapeutics Corp|SLN - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari Silence Therapeutics
Kompaniyaning fundamental tahlili:Silence Therapeutics - SLN
Silence Therapeutics PLC seriyali mahsuloti

Fundamental yetakchilarni tanlash uchun tahlilchi moliyaviy leveraj darajasini va aktivlar tuzilmasining barqarorligini aniqlash maqsadida umumiy majburiyatlarning balans kapitaliga nisbatini baholaydi. Silence Therapeutics (SLN) patentlariga tegishli geosiyosiy risklar fonida, balans kapitalizatsiyasidagi qarz konsentratsiyasining ushbu darajasi tolov qobiliyati ko'rsatkichi vazifasini o'taydi, bunda belgilangan normalardan oshib ketish klinik sinovlarning beqarorligi fonida defolt risklarining ortishidan signal beradi.

Silence Therapeutics (SLN) raqobatchilari

Qarzning balans kapitallashuviga nisbati TEM|Sof aktivlarga qarzlar qiagen.com QGEN|Balans kapitallashuviga qarzlar IONS (Ionis)|RGEN: Sof aktivlarga qarzlar|Avidity (RNA) - Qarzning balans kapitallashuviga nisbati|CRISPR (CRSP) - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar WGS (GeneDx Holdings Corp.)|Balans qiymatiga qarzlar RARE|Qarzning balans kapitallashuviga nisbati Beam Therapeutics BEAM|Qarzning balans qiymatiga nisbati Sarepta Therapeutics (SRPT)|Twist Bio - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati 10x TXG|NTLA (Intellia Therapeutics) - Balans kapitallashuviga qarzlar|stoketherapeutics.com (STOK) - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati BioLife Solutions BLFS|Qarzning sof aktivlarga nisbati Wave Life Sciences Ltd|Maze Tx (MAZE) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati Sionna Corp|Prime Medicine, Inc. (PRME) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati tayshagtx.com (TSHA)|QURE: Balans kapitallashuviga qarzlar|MeiraGTx Holdings - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Regenxbio (RGNX)|SLDB - Qarzning sof aktivlarga nisbati|OCGN: Balans kapitallashuviga qarzlar|PACB (pacb.com) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Benitec Biopharma BNTC|Qarzlarning balans kapitallashuviga nisbati Design Therapeutics Inc|Rocket Pharmaceuticals Inc - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar 4D Molecular Corp FDMT|Qarzning balans qiymatiga nisbati LXEO (Lexeo Therapeutics, Inc.)|KRRO - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Editas Medicine EDIT|PRQR - Qarzning balans kapitaliga nisbati|codexis.com - Balans kapitallashuviga qarzlar|Sangamo BioSciences (SGMO) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar NAUT|Qarzning balans qiymatiga nisbati MGX|DTIL (Precision BioSciences, Inc.) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar GBIO (generationbio.com)|Qarzning balans kapitallashuviga nisbati BOLD|Exicure Inc. - Sof aktivlarga qarzlar|IMNN - Qarzning balans kapitallashuviga nisbati|PHIO: Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati mustangbio.com|TransCode Therapeutics, Inc. (RNAZ) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Bionano Genomics Inc. (BNGO)|Qarzning balans qiymatiga nisbati APDN|Qarzning balans kapitallashuviga nisbati bluebird bio, Inc. BLUE|Qarzning balans qiymatiga nisbati immunoprecise.com (IPA)|Balans kapitallashuviga qarzlar OMGA (Omega Therapeutics, Inc.)|Singular Genomics Systems, Inc. - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati RGLS (Regulus Therapeutics Inc)|SYRS - Sof aktivlarga qarzlar|Telesis Bio, Inc. - Balans kapitallashuviga qarzlar|TCON (traconpharma.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Unity Biotechnology, Inc.